N-of-One Selected by Spectrum Health to Provide Clinical Interpretation for 50-Gene Hot-Spot Solid Tumor Panel

- Spectrum Health Cancer Center adopts N-of-One interpretation -

LEXINGTON, Mass.--()--N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed an agreement with Spectrum Health to provide clinical interpretation for all cases sequenced on Spectrum Health’s 50-gene hot-spot solid tumor panel. Spectrum Health is a not-for-profit health system offering a full continuum of care through the Spectrum Health Hospital Group, which is comprised of 12 hospitals. It is the largest cancer care provider in West Michigan. Financial terms of the agreement are not disclosed.

The Spectrum Health Cancer Center is focused on delivering individualized care to each cancer patient. A commitment to high-quality care and innovation has made Spectrum Health a regional leader and a referral center for cancer treatment.

“This is a wonderful opportunity for the Spectrum Health Cancer Center to expand our ability to provide personalized care and targeted therapies for our patients,” said Dr. Judy L. Smith, Chief of Oncology, Spectrum Health.

N-of-One's clinical interpretation provides the relevant scientific and clinical evidence related to the mutation profile of a tumor identified by sequencing, taking into account each patient’s specific molecular profile. This in turn links the clinical and scientific evidence to therapeutic strategies relevant for each patient.

“N-of-One’s clinical interpretation provides Spectrum Health with high-quality evidence and analysis that enables us to help physicians identify the best possible therapeutic strategies for their cancer patients,” said Dr. Cong Liu, Molecular Diagnostics Director at Spectrum Health. “This is a highly cost effective and efficient way for us to stay up-to-date on state-of-the art findings that are applicable to each patient.”

“N-of-One is very pleased to be working closely with Spectrum Health to deliver best-in-class, patient-specific clinical and scientific analysis that will support the pathologists in preparing Spectrum Health’s clinical reports,” said Chris Cournoyer, CEO at N-of-One. “Our objective is to provide high-quality. patient-specific clinical interpretation evidence at a cost-effective price.”

About Spectrum Health

Spectrum Health is a not-for-profit health system, based in West Michigan, offering a full continuum of care through the Spectrum Health Hospital Group, which is comprised of 12 hospitals, including Helen DeVos Children’s Hospital; 182 ambulatory and service sites; 1,300 physicians and advanced practice providers, including 1,100 members of the Spectrum Health Medical Group; and Priority Health, a health plan with more than 648,000 members. Spectrum Health is West Michigan’s largest employer, with 22,800 employees. The organization provided $294.6 million in community benefit during its 2014 fiscal year. Spectrum Health is the only health system in Michigan to be named one of the nation’s 15 Top Health Systems® by Truven Health Analytics for 2015. This is the fourth time the organization has received this recognition. spectrumhealth.org

About N-of-One

N-of-One, a leader in enabling precision medicine for oncology, leverages its world-class team of experts coupled with a highly proprietary platform that allows us to provide clinical solutions and services , such as molecular interpretation, to clinicians at the point of care. N-of-One’s team of experts has interpreted thousands of samples for oncologists and patients worldwide, through partnerships with leading diagnostic companies, hospital systems, directly to oncologists and through employee access benefit programs. N-of-One does not provide medical advice or promote any product or service. For more information, please visit www.n-of-one.com or call 617-202-9808.

Contacts

The Yates Network
Kathryn Morris, 845-635-9828
kathryn@theyatesnetwork.com

Release Summary

N-of-One has signed an agreement with Spectrum Health to provide clinical interpretation for all cases sequenced on Spectrum Health’s 50-gene hot-spot solid tumor panel.

Contacts

The Yates Network
Kathryn Morris, 845-635-9828
kathryn@theyatesnetwork.com